FDA Approved: AVSOLA — Original Application (Amgen, Inc)

View source ↗

Summary

FDA approved AVSOLA (infliximab-axxq) from Amgen as a biosimilar to infliximab, for the same indications as the reference product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Crohn Disease
• Plaque Psoriasis
• Psoriatic Arthritis
• Rheumatoid Arthritis
• Ulcerative Colitis

Drugs mentioned

• AVSOLA (Infliximab-axxq)

Snippet

ORIG AP for AVSOLA (INFLIXIMAB-AXXQ)